MedPath

Can turmeric powder treat asthma in children?

Phase 2
Conditions
Persistent asthma
Registration Number
RBR-9f3wwp
Lead Sponsor
Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Data analysis completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Children between 7 and 18 years; with a diagnostic of persistent asthma, mild, moderate or severe, controlled or not.

Exclusion Criteria

Allergy to C. longa; parental request; failure to adhere to the treatment.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Expected: Reduction of , classification of disease control , after 12 months , of at least one category , assessed by the method proposed by THOMAS; LEMANSKE; JACKSON, 2011.;Observed: Reduction of , classification of disease control , after 6 months , of at least one category , assessed by the method proposed by THOMAS; LEMANSKE; JACKSON, 2011.
Secondary Outcome Measures
NameTimeMethod
Expected: Decrease in , forced expiration volume in 1 second (FEV1) , after 12 months , of at least 10% , assessed by pulmonary lung function test (spirometry).;Observed: Decrease in , frequency of nighttime awakenings , after 6 months , of at least one category , assessed by the method proposed by THOMAS; LEMANSKE; JACKSON, 2011.;Observed: Decrease in , frequency of use of short-acting beta-adrenergic agonists , after 6 months , of at least one category , assessed by the method proposed by THOMAS; LEMANSKE; JACKSON, 2011.
© Copyright 2025. All Rights Reserved by MedPath